Cargando…

ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis

PURPOSE OF REVIEW: Elevated low-density lipoprotein cholesterol (LDL-C) and triglyceride-rich lipoproteins (TRLs) or remnants are important risk factors for the development of atherosclerotic cardiovascular disease (ASCVD). The ongoing challenge of not being able to achieve recommended LDL-C targets...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamed, Farzahna, Mansfield, Brett S., Raal, Frederick J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Genetics and Genomics (R.A. Hegele, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650658/ https://www.ncbi.nlm.nih.gov/pubmed/36367663 http://dx.doi.org/10.1007/s11883-022-01071-1

Ejemplares similares

Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond
por: Seidah, Nabil G., et al.
Publicado: (2022)

More than Just a Monolayer: the Multifaceted Role of Endothelial Cells in the Pathophysiology of Atherosclerosis
por: Mussbacher, Marion, et al.
Publicado: (2022)

Targeting PCSK9 and Beyond for the Management of Low-Density Lipoprotein Cholesterol
por: Mohamed, Farzahna, et al.
Publicado: (2023)

Hopf algebras and congruence subgroups
por: Sommerhauser, Yorck, et al.
Publicado: (2007)

Genetics of Triglycerides and the Risk of Atherosclerosis
por: Dron, Jacqueline S., et al.
Publicado: (2017)

Diet, Microbes, and Cancer Across the Tree of Life: a Systematic Review
por: Kapsetaki, Stefania E., et al.
Publicado: (2022)

Novel RNAi-Based Therapies for Atherosclerosis
por: Ruotsalainen, Anna-Kaisa, et al.
Publicado: (2021)

Statins: are they appropriate for all patients?
por: Raal, Frederick J, et al.
Publicado: (2022)

The Long Non-coding Road to Atherosclerosis
por: Josefs, Tatjana, et al.
Publicado: (2020)

Nucleic Acid–Based Therapies for Atherosclerosis
por: Mäkinen, Petri, et al.
Publicado: (2020)

ANGPTL3 gene variants in subjects with familial combined hyperlipidemia
por: Bea, A. M., et al.
Publicado: (2021)

ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome
por: Zhong, Fu, et al.
Publicado: (2022)

Acute Suppurative Thyroiditis Secondary to Escherichia coli Infection
por: Siddiqui, Nida, et al.
Publicado: (2021)

Circulating ANGPTL3 and ANGPTL4 levels predict coronary artery atherosclerosis severity
por: Sun, Ting, et al.
Publicado: (2021)

Impact of Right-Sided-Catheter-Based Valve Implantation on Decision-Making in Congenital Heart Disease
por: Ghobrial, Joanna, et al.
Publicado: (2016)

Building an Adult Congenital Heart Program: Critical Components and Important Allies
por: Thakkar, Akanksha, et al.
Publicado: (2018)

Update on Retinal Drug Toxicities
por: Hsu, S. Tammy, et al.
Publicado: (2021)

Targeted Temperature Management for Treatment of Cardiac Arrest
por: Rasmussen, Tyler P., et al.
Publicado: (2020)

The Genetic Basis of Hypertriglyceridemia
por: Carrasquilla, Germán D., et al.
Publicado: (2021)

Serum and urine ANGPTL8 expression levels are associated with hyperlipidemia and proteinuria in primary nephrotic syndrome
por: Li, Yue, et al.
Publicado: (2021)

Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4
por: Landfors, Fredrik, et al.
Publicado: (2022)

Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors
por: Pirillo, Angela, et al.
Publicado: (2021)

ANGPTL3 as therapeutic target
por: Kersten, Sander
Publicado: (2021)

Drug-drug interaction with oral antivirals for the early treatment of COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2023)

Adaptive evolution of major histocompatibility complex class I immune genes and disease associations in coastal juvenile sea turtles
por: Martin, Katherine R., et al.
Publicado: (2022)

Tissue-specific epigenetics of atherosclerosis-related ANGPT and ANGPTL genes
por: Ehrlich, Kenneth C, et al.
Publicado: (2019)

Dyslipidemia in South African patients with hypothyroidism
por: Mansfield, Brett S., et al.
Publicado: (2022)

Targeted Therapies in Brain Metastases
por: Lin, Nancy U.
Publicado: (2013)

Lipid Lowering Drugs: Present Status and Future Developments
por: Ruscica, Massimiliano, et al.
Publicado: (2021)

Targeted Therapies for Melanoma Brain Metastases
por: Berghoff, Anna S., et al.
Publicado: (2017)

Naptumomab Estafenatox: Targeted Immunotherapy with a Novel Immunotoxin
por: Eisen, Tim, et al.
Publicado: (2014)

WTH3 is a direct target of the p53 protein
por: Tian, K, et al.
Publicado: (2007)

Monkeypox is a global public health emergency: The role of repurposing cholesterol lowering drugs not to be forgotten
por: Vuorio, Alpo, et al.
Publicado: (2022)

The Future of Paediatric Heart Interventions: Where Will We Be in 2030?
por: Kogure, Tomohito, et al.
Publicado: (2020)

Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease
por: Kelly, Benjamin, et al.
Publicado: (2020)

Intensive Care Unit Management of the Adult with Congenital Heart Disease
por: Kendsersky, Payton, et al.
Publicado: (2020)

Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19
por: Wu, Eveline Y., et al.
Publicado: (2021)

MRI-Guided Cardiac Catheterization in Congenital Heart Disease: How to Get Started
por: Amin, Elena K., et al.
Publicado: (2022)

Rings and Slings: Not Such Simple Things
por: Ruiz-Solano, Elyan, et al.
Publicado: (2022)

Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles
por: Rickardson, L, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_o4psev26eft1flefpmh3nsubde